SCENT -CUTIE HAND SANITIZER
ChemWatch Material Safety Data Sheet
CHEMWATCH 4811-18
Date of Issue: Wed 11-Jun-2003
PRODUCT NAME
SCENT -CUTIE HAND SANITIZER
STATEMENT OF HAZARDOUS NATURE
CONSIDERED A DANGEROUS SUBSTANCE ACCORDING TO DIRECTIVE
67/548/EEC, POINT 4; AND
HAZARDOUS ACCORDING TO OSHA 29 CFR 1910.1200 (USA).
SUPPLIER
Company:
Double Class (M) Sdn Bhd
Address:
No.14, Jalan 4
Pandan Inidah Industrial Park,
Kuala Lumpur, 55100
Malaysia
Telephone: +60 3 4280 9898
CONTACT
National Poisons Center of Malaysia
1800 888 099 (office hours)
MOLECULAR MASS
Molecular mass: Not Applicable
PRODUCT USE
Waterless hand sanitizer.
SYNONYMS
Section 2 - COMPOSITION / INFORMATION ON INGREDIENTS
NAME R CODE INT HAZ %
ethanol R11,R36 F+,Xi >60
CAS RN: 64-17-5
propylene glycol None None 1-5
CAS RN: 57-55-6
triethanolamine R36 Xi 0-0.3
CAS RN: 102-71-6
carbomer 940 0-0.3
water None None 10-30
CAS RN: 7732-18-5
Section 3 - PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL PROPERTIES
Liquid.
Mixes with water.
Molecular Weight: Not Applicable
Boiling Range (癈): Not Available
Melting Range (癈): Not Available
Specific Gravity (water=1): Not Available
Solubility in water (g/L): Miscible
pH (as supplied): Not Available
pH (1% solution): Not Available
Vapour Pressure (kPa): Not Available
Volatile Component (%vol): Not Available
Evaporation Rate: Not Available
Relative Vapour Density (air=1): Not Available
Flash Point (癈): <23
Lower Explosive Limit (%): Not Available
Upper Explosive Limit (%): Not Available
Autoignition Temp (癈): Not Available
Decomposition Temp (癈): Not Available
State: Liquid
APPEARANCE
Highly flammable liquid; soluble in water.
Section 4 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
RISK
In use, may form flammable/explosive vapour-air mixture.
Can become highly flammable in use.
Irritating to eyes and respiratory system.
Highly flammable.
Vapours potentially cause drowsiness and dizziness*.
Cumulative effects may result following exposure*.
May produce skin discomfort*.
Possible skin sensitiser*.
Inhalation and/or ingestion may produce health damage*.
* (limited evidence).
POTENTIAL HEALTH EFFECTS
ACUTE HEALTH EFFECTS
SWALLOWED
Accidental ingestion of the material may be damaging to the health of the
individual; animal experiments indicate that ingestion of less than 150 gram may
be fatal.
EYE
Evidence exists, or practical experience predicts, that the material may cause
eye irritation in a substantial number of individuals and/or may produce
significant ocular lesions which are present twenty-four hours or more after
instillation into the eye(s) of experimental animals.
SKIN
Limited evidence exists, or practical experience predicts, that the material
either produces inflammation of the skin in a substantial number of individuals
following direct contact, and/or produces significant inflammation when applied
to the healthy intact skin of animals, for up to four hours, such inflammation
being present twenty-four hours or more after the end of the exposure period.
Skin contact is not thought to harmful health effects (as classified under EC
Directives); the material may still produce health damage following entry
through wounds, lesions or abrasions.
INHALED
Inhalation may produce health damage*.
Evidence shows, or practical experience predicts, that the material produces
irritation of the respiratory system in a substantial number of individuals
following inhalation.
Vapours potentially cause drowsiness and dizziness*.
CHRONIC HEALTH EFFECTS
Cumulative effects may
result following exposure*.
There exists limited evidence that shows that skin contact with the material is
capable either of inducing a sensitisation reaction in a significant number of
individuals, and/or of producing positive response in experimental animals.
There is limited evidence that, skin contact with this product is more likely to
cause a sensitisation reaction in some persons compared to the general
population.
Prolonged exposure to ethanol may cause damage to the liver and cause scarring.
It may also worsen damage caused by other agents. Large amounts of ethanol taken
in pregnancy may result in "foetal alcohol syndrome", characterised by delay in
mental and physical development, learning difficulties, behavioural problems and
small head size. A small number of people develop allergic reactions to ethanol,
which include eye infections, skin swelling, shortness of breath, and itchy
rashes with blisters.
Prolonged or chronic exposure to alkanolamines may result in liver, kidney or
nervous system injury. Repeated inhalation may aggravate asthma and inflammatory
or fibrotic pulmonary disease.
Results of repeated exposure tests with diethanolamine (DEA) in laboratory
animals include anaemia (rats) and effects on the kidneys (rats and mice) and
liver (mice). DEA produces nervous system injury in dogs and rats. Heart and
salivary gland lesions have also been seen in mice treated cutaneously with DEA
and in mice receiving DEA in drinking water. Rats given high doses of DEA
developed anaemia and testicular lesions.
Exaggerated doses of DEA produced heart and nervous system effects in other
animals. Changes in other organs were judged to be secondary due to the poor
health of animals subjected to extremely high doses of DEA. Rats, rabbits and
guinea pigs exposed to high vapour concentrations of volatile monoethanolamine
(MEA) (up to 1250 ppm) for periods of up to 5 weeks developed pulmonary, hepatic
and renal lesions. Dogs, rats and guinea pigs exposed to 100 ppm MEA for 30
days, became apathetic and developed poor appetites. Animal tests also indicate
that inhalation exposure to MEA may result in nervous system injury. All species
exposed to airborne MEA experienced dermal effects, varying from ulceration to
hair loss probably resulting from contact with the cage.
An increased incidence of skeletal variations, suggestive of a slight
developmental delay was seen in the foetuses of rats given 1500 mg/kg/day DEA
cutaneously; this also produced significant maternal toxicity. No foetal
malformations, however, were seen in rats nor in rabbits receiving identical
treatment. The foetus of rats given high doses of MEA by gavage, showed an
increased rate of embryofoetal death, growth retardation, and some malformations
including hydronephrosis and hydroureter. The high doses required to produce
these effects bring into question the relevance of this finding to humans. There
is some evidence that embryofoetotoxicity and teratogenicity does not occur in
rats when MEA is administered by dermal application to the mother.
The National Toxicology Program (NTP) concluded that there is clear evidence of
liver tumours and some evidence of kidney tumours in mice exposed dermally to
DEA over their lifetime. Chronic skin painting studies in mice of both sexes
produced liver tumours and an increased incidence of kidney tumours in male
mice. The significance of these findings to humans is unclear as DEA is neither
genotoxic, mutagenic nor clastogenic, and did not induce tumours in rats or
transgenic mice similarly treated. Alkanolamines (especially those containing a
secondary amine moiety) may react with nitrites or other nitrosating agents to
form carcinogenic N-nitrosamines. Alkanolamines are metabolised by biosynthetic
routes to ethanolamine and choline and incorporated into phospholipids. They are
excreted predominantly unchanged with a half-life of approximately one week. In
the absence of sodium nitrite, no conversion to carcinogenic N-nitrosamines are
observed.
Diethanolamine competitively inhibits the cellular uptake of choline, in vitro,
and hepatic changes in choline homeostasis, consistent with choline deficiency,
are observed in vivo.
Many amines are potent skin and respiratory sensitisers and certain individuals
especially those described as "atopic" (i.e. those predisposed to asthma and
other allergic responses) may show allergic reactions when chronically exposed
to alkanolamines.
In a study with coconut diethanolamide, the National Toxicology Program
(Technical Report Series 479), showed clear evidence of carcinogenic activity in
male B6C3F1 mice based on increased incidences of hepatic and renal tubule
neoplasms and in female B6C3F1 mice based on increased incidences of hepatic
neoplasms. There was equivocal evidence of carcinogenic activity in female
F344/N rats based on a marginal increase in the incidence of renal tube
neoplasms. These increases were associated with the concentration of free
diethanolamine present as a contaminant in the diethanolamine condensate.
Exposure to rats to coconut oil diethanolamine condensate by dermal application
in ethanol for 2-years resulted in epidermal hyperplasia, sebaceous gland
hyperplasia, hyperkeratosis and parakeratosis in males and females and ulcer in
females at the site of application. There were increases in the incidences of
chronic inflammation, epithelial hyperplasia, and epithelial ulcer in the
forestomach of female rats. The severity of nephropathy in dosed female rats
were increased. Exposure of mice to coconut oil diethanolamine condensate by
dermal application for 2-years resulted in increased incidences of eosinophilic
foci of the liver in males. Increased incidences of epidermal hyperplasia,
sebaceous gland hyperplasia, and hyperkeratosis in males and females, ulcer in
males, and parakeratosis and inflammation in females at the site of application
and of follicular cell hyperplasia in the thyroid gland of males and females,
were chemical related.
Section 5 - FIRST AID MEASURES
SWALLOWED
DO NOT induce vomiting.
If vomiting occurs, lean patient forward or place on left side (head-down
position, if possible) to maintain open airway and prevent aspiration.
Observe the patient carefully.
Never give liquid to a person showing signs of being sleepy or with reduced
awareness; i.e. becoming unconscious.
Give water (or milk) to rinse out mouth, then provide liquid slowly and as much
as casualty can comfortably drink.
Transport to hospital or doctor without delay.
EYE
If this product comes in contact with the eyes:
Immediately hold the eyes open and wash with fresh running water.
Ensure complete irrigation of the eye by keeping eyelids apart and away from eye
and moving the eyelids by occasionally lifting the upper and lower lids.
If pain persists or recurs seek medical attention.
Removal of contact lenses after an eye injury should only be undertaken by
skilled personnel.
SKIN
If product comes in contact with the skin:
Immediately remove all contaminated clothing, including footwear
Wash affected areas thoroughly with water (and soap if available).
Seek medical attention in event of irritation.
INHALED
If fumes or combustion products are inhaled: Remove to fresh air.
Lay patient down. Keep warm and rested.
Prostheses such as false teeth, which may block airway, should be removed, where
possible, prior to initiating first aid procedures
If breathing is shallow or has stopped, ensure clear airway and apply
resuscitation, preferably with a demand valve resuscitator, bag-valve mask
device, or pocket mask as trained. Perform CPR if necessary.
Transport to hospital, or doctor.
NOTES TO PHYSICIAN
Treat symptomatically.
For acute or short term repeated exposures to ethanol:
Acute ingestion in non-tolerant patients usually responds to supportive care
with special attention to prevention of aspiration, replacement of fluid and
correction of nutritional deficiencies (magnesium, thiamine pyrodoxine, Vitamins
C K)
Give 50% dextrose (50-100 ml) IV to obtunded patients following blood draw for
glucose determination.
Comatose patients should be treated with initial attention to airway, breathing,
circulation and drugs of immediate importance (glucose, thiamine)
Decontamination is probably unnecessary more than 1 hour after a single observed
ingestion. Cathartics and charcoal may be given but are probably not effective
in single ingestions.
Fructose administration is contra-indicated due to side effects.
Section 6 - FIRE FIGHTING MEASURES
EXTINGUISHING MEDIA
Water spray or fog.
Foam.
Dry chemical powder.
BCF (where regulations permit).
Carbon dioxide.
FIRE FIGHTING
Alert Fire Brigade and tell them location and nature of hazard.
May be violently or explosively reactive.
Wear breathing apparatus plus protective gloves.
Prevent, by any means available, spillage from entering drains or water course.
Consider evacuation (or protect in place).
Fight fire from a safe distance, with adequate cover.
If safe, switch off electrical equipment until vapour fire hazard removed.
Use water delivered as a fine spray to control the fire and cool adjacent area.
Avoid spraying water onto liquid pools.
Do not approach containers suspected to be hot.
Cool fire exposed containers with water spray from a protected location.
If safe to do so, remove containers from path of fire.
When any large container (including road and rail tankers) is involved in a fire,
consider evacuation by 500 metres in all directions.
FIRE/EXPLOSION HAZARD
Liquid and vapour are highly flammable.
Severe fire hazard when exposed to heat, flame and/or oxidisers.
Vapour may travel a considerable distance to source of ignition.
Heating may cause expansion or decomposition leading to violent rupture of
containers.
On combustion, may emit toxic fumes of carbon monoxide (CO).
Combustion products include
carbon dioxide (CO2)
other pyrolysis products typical of burning organic material
FIRE INCOMPATIBILITY
Avoid contamination with oxidising agents i.e. nitrates, oxidising acids,
chlorine bleaches, pool chlorine etc. as ignition may result
Section 7 - ACCIDENTAL RELEASE MEASURES
MINOR SPILLS
Remove all ignition sources.
Clean up all spills immediately.
Avoid breathing vapours and contact with skin and eyes.
Control personal contact by using protective equipment.
Contain and absorb small quantities with vermiculite or other absorbent
material.
Wipe up.
Collect residues in a flammable waste container.
MAJOR SPILLS
Clear area of personnel and move upwind.
Alert Fire Brigade and tell them location and nature of hazard.
May be violently or explosively reactive.
Wear breathing apparatus plus protective gloves.
Prevent, by any means available, spillage from entering drains or water course.
Consider evacuation (or protect in place).
No smoking, naked lights or ignition sources.
Increase ventilation.
Stop leak if safe to do so.
Water spray or fog may be used to disperse /absorb vapour.
Contain spill with sand, earth or vermiculite.
Use only spark-free shovels and explosion proof equipment.
Collect recoverable product into labelled containers for recycling.
Absorb remaining product with sand, earth or vermiculite.
Collect solid residues and seal in labelled drums for disposal.
Wash area and prevent runoff into drains.
If contamination of drains or waterways occurs, advise emergency services.
PROTECTIVE ACTIONS FOR SPILL
From IERG (Canada/Australia)
Isolation Distance 25 metres
Downwind Protection Distance 300 metres
FOOTNOTES
1 PROTECTIVE ACTION ZONE is defined as the area in which people are at risk
of harmful exposure. This zone assumes that random changes in wind direction
confines the vapour plume to an area within 30 degrees on either side of the
predominant wind direction, resulting in a crosswind protective action distance
equal to the downwind protective action distance.
2 PROTECTIVE ACTIONS should be initiated to the extent possible, beginning with
those closest to the spill and working away from the site in the downwind
direction. Within the protective action zone a level of vapour concentration
may exist resulting in nearly all unprotected persons becoming incapacitated
and unable to take protective action and/or incurring serious or irreversible
health effects.
3 INITIAL ISOLATION ZONE is determined as an area, including upwind of the
incident, within which a high probability of localised wind reversal may
expose nearly all persons without appropriate protection to life-threatening
concentrations of the material.
4 SMALL SPILLS involve a leaking package of 200 litres (55 US gallons) or less,
such as a drum (jerrican or box with inner containers). Larger packages leaking
less than 200 litres and compressed gas leaking from a small cylinder are also
considered "small spills".
LARGE SPILLS involve many small leaking packages or a leaking package of
greater than 200 litres, such as a cargo tank, portable tank or a "one-tonne"
compressed gas cylinder.
5 Guide 127 is taken from the US DOT emergency response guide book.
6 IERG information is derived from CANUTEC - Transport Canada.
Section 8 - HANDLING AND STORAGE
PROCEDURE FOR HANDLING
Avoid all personal contact, including inhalation.
Wear protective clothing when risk of exposure occurs.
Use in a well-ventilated area.
Prevent concentration in hollows and sumps.
DO NOT enter confined spaces until atmosphere has been checked.
Avoid smoking, naked lights, heat or ignition sources.
When handling, DO NOT eat, drink or smoke.
Vapour may ignite on pumping or pouring due to static electricity.
DO NOT use plastic buckets.
Earth and secure metal containers when dispensing or pouring product.
Use spark-free tools when handling.
Avoid contact with incompatible materials.
Keep containers securely sealed.
Avoid physical damage to containers.
Always wash hands with soap and water after handling.
Work clothes should be laundered separately.
Use good occupational work practice.
Observe manufacturer's storing and handling recommendations.
Atmosphere should be regularly checked against established exposure standards to
ensure safe working conditions.
DO NOT allow clothing wet with material to stay in contact with skin
SUITABLE CONTAINER
Packing as supplied by manufacturer. Plastic containers may only be used if
approved for flammable liquid. Check that containers are clearly labelled and
free from leaks.
For low viscosity materials (i) : Drums and jerricans must be of the
non-removable head type. (ii) : Where a can is to be used as an inner package,
the can must have a screwed enclosure.
For materials with a viscosity of at least 2680 cSt. (23 deg. C)
For manufactured product having a viscosity of at least 250 cSt. (23 deg. C)
Manufactured product that requires stirring before use and having a viscosity of
at least 20 cSt (25 deg. C)
(i) : Removable head packaging;
(ii) : Cans with friction closures and
(iii) : low pressure tubes and cartridges may be used.
Where combination packages are used, and the inner packages are of glass, there
must be sufficient inert cushioning material in contact with inner and outer
packages
In addition, where inner packagings are glass and contain liquids of packing
group I there must be sufficient inert absorbent to absorb any spillage, unless
the outer packaging is a close fitting moulded plastic box and the substances
are not incompatible with the plastic.
STORAGE INCOMPATIBILITY
Incompatible with aluminium. DO NOT heat above 49 deg. C. in aluminium
equipment.
Avoid reaction with oxidising agents
Segregate from
strong oxidisers
STORAGE REQUIREMENTS
Store in original containers in approved flame-proof area.
No smoking, naked lights, heat or ignition sources.
DO NOT store in pits, depressions, basements or areas where vapours may be
trapped.
Keep containers securely sealed.
Store away from incompatible materials in a cool, dry well ventilated area.
Protect containers against physical damage and check regularly for leaks.
Observe manufacturer's storing and handling recommendations.
Section 9 - EXPOSURE CONTROLS / PERSONAL PROTECTION
EXPOSURE CONTROLS
No data for SC Scent -Cutie Hand Sanitizer.
EXPOSURE STANDARDS FOR MIXTURE
"Worst Case" computer-aided prediction of vapour components/concentrations:
Composite Exposure Standard for Mixture (TWA) (mg/m?: 1614.0229 mg/m?br>
If the breathing zone concentration of ANY of the components listed below is
exceeded, "Worst Case" considerations deem the individual to be over
overexposed.
Component Breathing Zone ppm Breathing Zone mg/m?Mixture Conc: (%)
propylene glycol 28.38 89.6679 5
ethanol 810.83 1524.355 85
Operations which produce a spray/mist or fume/dust, introduce particulates to
the breathing zone.
If the breathing zone concentration of ANY of the components listed below is
exceeded, "Worst Case" considerations deem the individual to be over
overexposed.
At the "Composite Exposure Standard for Mixture" (TWA) (mg/m?: 90 mg/m?br>
Component Breathing Zone ppm Breathing Zone mg/m?Mixture Conc (%)
triethanolamine 0 0 0
REPRODUCTIVE HEALTH GUIDELINES
Established occupational exposure limits frequently do not take into
consideration reproductive end points that are clearly below the thresholds for
other toxic effects. Occupational reproductive guidelines (ORGs) have been
suggested as an additional standard. These have been established after a
literature search for reproductive no-observed-adverse effect-level (NOAEL) and
the lowest-observed-adverse-effect-level (LOAEL). In addition the US EPA's
procedures for risk assessment for hazard identification and dose-response
assessment as applied by NIOSH were used in the creation of such limits.
TLV
Ingredient ORG UF Endpoint CR Adeq
ethanol 1880 mg/m? NA NA NA Yes
These exposure guidelines have been derived from a screening level of risk
assessment and should not be construed as unequivocally safe limits. ORGS
represent an 8-hour time-weighted average unless specified otherwise.
CR = Cancer Risk/10000; UF = Uncertainty factor:
TLV believed to be adequate to protect reproductive health:
LOD: Limit of detection
Toxic endpoints have also been identified as:
D = Developmental; R = Reproductive; TC = Transplacental carcinogen
Jankovic J., Drake F.: A Screening Method for Occupational Reproductive
American Industrial Hygiene Association Journal 57: 641-649 (1996)
INGREDIENT DATA
ETHANOL:
TLV TWA: 1000 ppm A4 [ACGIH]
PEL TWA: 1000 ppm, 1900 mg/m?[OSHA Z1]
TLV TWA: 1000 ppm, 1880 mg/m?A4
NOTE: This substance has been classified by the ACGIH as A4 NOT classifiable as
causing Cancer in humans
ES TWA: 1000 ppm, 1880 mg/m?br>
OES TWA: 1000 ppm, 1920 mg/m?br>
MAK value: 500 ppm, 960 mg/m?br>
MAK Category II Peak Limitation: For substances with systemic effects and with a
half-life in humans of less than two hours.
Allows excursions of 2 times the MAK value, for 30 minutes (on average), four
times per shift.
MAK Group C: There is no reason to fear risk of damage to the developing embryo
when MAK and BAT values are observed.
MAK values, and categories and groups are those recommended within the
Federal Republic of Germany
Odour Threshold Value: 49-716 ppm (detection), 101 ppm (recognition)
IDLH Level: 3300 ppm (lower explosive limit)
Eye and respiratory tract irritation do not appear to occur at exposure
levels of less than 5000 ppm and the TLV-TWA is thought to provide an
adequate margin of safety against such effects.
Experiments in man show that inhalation of 1000 ppm caused slight symptoms
of poisoning and 5000 ppm caused strong stupor and morbid sleepiness.
Subjects exposed to 5000 ppm to 10000 ppm experienced smarting of the
eyes and nose and coughing. Symptoms disappeared within minutes.
Inhalation also causes local irritating effects to the eyes and
upper respiratory tract, headaches, sensation of heat intraocular
tension, stupor, fatigue and a need to sleep.
At 15000 ppm there was continuous lachrymation and coughing.
PROPYLENE GLYCOL:
ES TWA: 150 ppm, 474 mg/m?(total vapour and particulates)
ES TWA: 10 mg/m?(particulates only)
OES TWA: 150 ppm, 474 mg/m?(total, vapour and particulates)
OES TWA: 10 mg/m?(particulates)
Saturated vapour concentration @ 20 deg C.= 65.8 ppm, 204.6 mg/m? i.e
higher concentrations can only occur as aerosols or at higher temperatures.
Odour Threshold: Practically odourless.
A small number of individuals show skin irritation or sensitisation from
repeated or prolonged exposure to propylene glycol. A workplace
environmental exposure limit (WEEL) has been established by AIHA and is
thought to be protective against systemic effects.
TRIETHANOLAMINE:
TLV TWA: 5 mg/m?[ACGIH]
TLV TWA: 5 mg/m?br>
ES TWA: 5 mg/m?sensitiser
Exposure at or below the TLV-TWA is thought to minimise the potential for
skin and eye irritation, and acute effects (including liver, kidney and
nerve damage) and chronic effects (including cancer and allergic contact
dermatitis).
WATER:
No exposure limits set by NOHSC or ACGIH
PERSONAL PROTECTION
EYE
Safety glasses with side shields.
Chemical goggles.
Contact lenses pose a special hazard; soft lenses may absorb irritants and all
lenses concentrate them. DO NOT wear contact lenses.
HANDS/FEET
Wear chemical protective gloves, eg. PVC.
Wear safety footwear or safety gumboots, eg. Rubber
NOTE: The material may produce skin sensitisation in predisposed individuals.
Care must be taken, when removing gloves and other protective equipment, to
avoid all possible skin contact.
OTHER
Overalls.
PVC Apron.
PVC protective suit may be required if exposure severe.
Eyewash unit.
Ensure there is ready access to a safety shower.
GLOVE SELECTION INDEX
Glove selection is based on a modified presentation of the:
"Forsberg Clothing Performance Index".
The effect(s) of the following substance(s) are taken into account in the
computer-generated selection:
Substance
________________________________________
ethanol
water
BUTYL A
PE/EVAL/PE A
NEOPRENE A
NATURAL RUBBER C
* CPI - Chemwatch Performance Index
A: Best Selection
B: Satisfactory; may degrade after 4 hours continuous immersion
C: Poor to Dangerous Choice for other than short term immersion
NOTE: As a series of factors will influence the actual performance of the glove,
a final selection must be based on detailed observation. -
* Where the glove is to be used on a short term, casual or infrequent basis,
factors such as "feel" or convenience (e.g. disposability), may dictate a choice
of gloves which might otherwise be unsuitable following long-term or frequent
use. A qualified practitioner should be consulted.
RESPIRATOR
Respiratory protection may be required when ANY "Worst Case" vapour-phase
concentration is exceeded (see Computer Prediction in "Exposure Standards").
Protection Factor Half-Face Respirator Full-Face Respirator
5 x ES Air-line* AK-2
- AK-PAPR-2
10 x ES - AK-3
10+ x ES - Air-line**
* - Continuous Flow; ** - Continuous-flow or positive pressure demand
^ - Full-face
The local concentration of material, quantity and conditions of use determine
the type of personal protective equipment required. For further information
consult site specific CHEMWATCH data (if available), or your Occupational
Health and Safety Advisor.
ENGINEERING CONTROLS
For flammable liquids and flammable gases, local exhaust ventilation or a
process enclosure ventilation system may be required. Ventilation equipment
should be explosion-resistant
Air contaminants generated in the workplace possess varying "escape" velocities
which, in turn, determine the "capture velocities" of fresh circulating air
required to effectively remove the contaminant.
Type of Contaminant: Air Speed:
solvent, vapours, degreasing etc., 0.25-0.5 m/s (50-100 f/min.)
evaporating from tank (in still air).
aerosols, fumes from pouring 0.5-1 m/s (100-200 f/min.)
operations, intermittent container
filling, low speed conveyer transfers,
welding, spray drift, plating acid
fumes, pickling (released at low
velocity into zone of active
generation)
direct spray, spray painting in shallow 1-2.5 m/s (200-500 f/min.)
booths, drum filling, conveyer loading,
crusher dusts, gas discharge (active
generation into zone of rapid air
motion)
Within each range the appropriate value depends on:
Lower end of the range Upper end of the range
1: Room air currents minimal or 1: Disturbing room air currents
favourable to capture
2: Contaminants of low toxicity or of 2: Contaminants of high toxicity
nuisance value only.
3: Intermittent, low production. 3: High production, heavy use
4: Large hood or large air mass in 4: Small hood-local control only
motion
Simple theory shows that air velocity falls rapidly with distance away from the
opening of a simple extraction pipe. Velocity generally decreases with the
square of distance from the extraction point (in simple cases). Therefore the
air speed at the extraction point should be adjusted, accordingly, after
reference to distance from the contaminating source. The air velocity at the
extraction fan, for example, should be a minimum of 1-2 m/s (200-400 f/min.) for
extraction of solvents generated in a tank 2 meters distant from the extraction
point. Other mechanical considerations, producing performance deficits within
the extraction apparatus, make it essential that theoretical air velocities are
multiplied by factors of 10 or more when extraction systems are installed or
used.
Section 10 - CHEMICAL STABILITY AND REACTIVITY
INFORMATION
CONDITIONS CONTRIBUTING TO INSTABILITY
Segregate from
strong oxidisers
Section 11 - TOXICOLOGICAL INFORMATION
SC Scent -Cutie Hand Sanitizer
ETHANOL:
TOXICITY IRRITATION
Oral (rat) LD50: 7060 mg/kg Skin (rabbit):20 mg/24hr-moderate
Oral (human) LDLo: 1400 mg/kg Skin (rabbit):400 mg (open)-mild
Oral (man) TDLo: 50 mg/kg Eye (rabbit):100mg/24hr-moderate
Oral (man) TDLo: 1.40 mg/kg Eye (rabbit): 500 mg SEVERE
Oral (woman) TDLo: 256 mg/kg/12 wks
Inhalation (rat) LC50: 20,000 ppm/10h
PROPYLENE GLYCOL:
TOXICITY IRRITATION
Oral (rat) LD50: 20000 mg/kg Skin(human):500 mg/7days mild
Dermal (rabbit) LD50: 20800 mg/kg Skin(human):104 mg/3d Intermit Mod
Eye (rabbit): 100 mg - mild
Eye (rabbit): 500 mg/24h - mild
TRIETHANOLAMINE:
TOXICITY IRRITATION
Oral (rat) LD50: 8000 mg/kg Skin (human): 15 mg/3d (int)-mild
Oral (rat) LD50: 4920 ul/kg Skin (rabbit): 560 mg/24 hr- mild
Oral (rat) LD50: 5560 mg/kg (calc.) Eye (rabbit): 5.62 mg - SEVERE
Oral (rat) LD50: 4.92 ml/kg (female) * Eye (rabbit): 10 mg - mild
Oral (rat) LD50: 8.57 ml/kg (male) * Eye (rabbit): 0.1 ml -
Dermal (rat) LD50: >16000 mg/kg minor iritis,
Dermal (rabbit) LD50: 16 ml/kg * minor conjunctival irritation
(occluded, male or female) with significant discharge;
Kill rate 1/5 * no corneal injury *
Intraperitoneal (rat) LD50: 1510 mg/kg Skin (rabbit): 4 h occluded
Oral (mouse) LD50: 5846 mg/kg no irritation *
Intraperitoneal (mouse) LD50: 1450 mg/kg
Oral (rabbit) LD50: 2200 mg/kg
Dermal (rabbit) LD50: >20000 mg/kg
Oral (g.pig) LD50: 2200 mg/kg
Lachrymation, diarrhoea, convulsions, urinary tract changes, changes in
bladder weight, changes in testicular weight, changes in thymus weight,
changes in liver weight, dermatitis after systemic exposure, kidney,
ureter, bladder tumours recorded.
Equivocal tumourigen by RTECS criteria.
* Union Carbide
The substance is classified by IARC as Group 3:
NOT classifiable as to its carcinogenicity to humans.
Evidence of carcinogenicity may be inadequate or limited in animal testing.
NOTE: Substance has been shown to be mutagenic in at least one assay, or belongs
to a family of chemicals producing damage or change to cellular DNA.
Limited evidence of a carcinogenic effect*.
WATER:
No significant acute toxicological data identified in literature search.
Section 12 - ECOLOGICAL INFORMATION
DO NOT discharge into sewer or waterways.
Section 13 - DISPOSAL CONSIDERATIONS
Recycle wherever possible.
Consult manufacturer for recycling options or consult local or regional waste
management authority for disposal if no suitable treatment or disposal facility
can be identified.
Dispose of by: Burial in a licenced land-fill or Incineration in a licenced
apparatus (after admixture with suitable combustible material)
Decontaminate empty containers. Observe all label safeguards until containers
are cleaned and destroyed.
(class 6, sub1|sub2 6, Xn)
Puncture containers to prevent re-use and bury at an authorised landfill.
Section 14 - TRANSPORTATION INFORMATION
None
Hazard Class: None, None
UN/NA Number: 2[Y]E
Packing Group: 14
Labels Required:
Additional Shipping Information:
International Transport Regulations:
IMO: 1170
Section 15 - REGULATORY INFORMATION
RISK
In use, may form flammable/explosive vapour-air mixture.
Can become highly flammable in use.
Irritating to eyes and respiratory system.
Highly flammable.
Vapours potentially cause drowsiness and dizziness*.
Cumulative effects may result following exposure*.
May produce skin discomfort*.
Possible skin sensitiser*.
Inhalation and/or ingestion may produce health damage*.
* (limited evidence).
SAFETY
Do not breathe dust.
Wear eye/ face protection.
Use only in well ventilated areas.
To clean the floor and all objects contaminated by this material, use water.
Take off immediately all contaminated clothing.
In case of contact with eyes, rinse with plenty of water and contact Doctor or
Poisons Information Centre.
If swallowed, IMMEDIATELY contact Doctor or Poisons Information Centre (show
this container or label).
If you feel unwell contact Doctor or Poisons Information Centre (show the label
if possible).
Section 16 - OTHER INFORMATION
This document is copyright. Apart from any fair dealing for the purposes of
private study, research, review or criticism, as permitted under the Copyright
Act, no part may be reproduced by any process without written permission from
CHEMWATCH. TEL (+61 3) 9572 4700.
Issue Date: Wed 11-Jun-2003
Print Date: Thu 12-Jun-2003
|